Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Iliana Alejandra Cortés-OrtízGenetics and Molecular Diagnostics Laboratory, Hospital Juárez de México, Mexico City 0776, Mexico.ORCID 0000-0001-9409-5896
Enoc Mariano Cortés-MalagónResearch Division, Hospital Juárez de México, Mexico City 07760, Mexico.ORCID 0000-0002-6240-3468
Eduardo García-MoncadaGenetics and Molecular Diagnostics Laboratory, Hospital Juárez de México, Mexico City 0776, Mexico.ORCID 0000-0001-9817-6183
Gustavo Acosta-AltamiranoHospital General de México, Mexico City 06726, Mexico.
Jesús Alejandro Pineda-MigranasFacultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Cuautitlán Izcalli 54740, Mexico.ORCID 0009-0002-6498-6684
Karen Lizzet García-PrudencioFacultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Cuautitlán Izcalli 54740, Mexico.ORCID 0009-0002-8632-7508
Edgar Mendieta-CondadoState Public Health Laboratory, Jalisco Health Services, Zapopan 45177, Mexico.ORCID 0000-0002-1041-0965
Adnan Araiza-RodríguezUnit of Technological Development and Molecular Research, Instituto de Diagnóstico y Referencia Epidemiológicos (InDRE) "Dr. Manuel Martínez Báez", Secretaría de Salud, Mexico City 01480, Mexico.
Alejandra Yareth Bonilla-CortésSchool of Medicine and Homeopathy, Instituto Politécnico Nacional, Mexico City 07320, Mexico.ORCID 0000-0003-3928-8438
Mónica Sierra-MartínezHealth Research Unit, Hospital de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Ixtapaluca 56530, Mexico.ORCID 0000-0002-1006-592X
Juan Carlos Bravata-AlcántaraHealth Research Unit, Hospital de Alta Especialidad de Ixtapaluca, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Ixtapaluca 56530, Mexico.ORCID 0000-0002-3585-0051
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
The global emergence of multidrug- and pandrug-resistant
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Clonal Dissemination of Pandrug-Resistant · full record | Socratic